Eculizumab use throughout pregnancy in two patients with aquaporin‐4‐positive neuromyelitis optica spectrum disorder

Documenti analoghi

• Response to: Eculizumab use throughout pregnancy in two patients with aquaporin‐4‐positive neuromyelitis optica spectrum disorder
  di: Ilya Kister, et al.
  Pubblicazione: (2024)
• Effects of transcranial direct current stimulation on multiple sclerosis and neuromyelitis optica spectrum disorder: A double‐blind, randomized, crossover trial
  di: Ryoko Shibuya, et al.
  Pubblicazione: (2025)
• Impact of Prior Intravenous Immunoglobulin and Plasmapheresis on Eculizumab or Ravulizumab Treatment for Generalized Myasthenia Gravis: An Analysis of the MG SPOTLIGHT Registry
  di: Akiyuki Uzawa, et al.
  Pubblicazione: (2025)
• Exploring digital biomarkers using smartphones for fatigue assessment in patients with multiple sclerosis
  di: Kenzo Sakurai, et al.
  Pubblicazione: (2024)
• Expert teleconsultation involving patients and their primary neurologists for the management of multiple sclerosis in regions without specialists
  di: Yusei Miyazaki, et al.
  Pubblicazione: (2024)